Our reports provide an independent, expert view supported by robust and innovative data interrogation and analysis.

Refine Sector
Sub-Category
Clear
Publish Date
Clear
Region
Clear
Clear All
Sort by:
Global Cardiovascular Disease Drugs Market to 2023 – Expiries, Acquisitions and New Products for Deep Vein Thrombosis, Pulmonary Arterial Hypertension and Dyslipidemia to Shake-Up the Competitive Landscape

Published: Dec-2017

The cardiovascular disease (CVD) therapy area encompasses a range of different diseases and conditions affecting the heart.....

$4995
More Info
COPD Therapeutics in Asia-Pacific Markets to 2023 – Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies

Published: Dec-2017

Chronic obstructive pulmonary disease (COPD) is a term that refers to a large group of lung diseases characterized by.....

$4995
More Info
Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long-Acting Replacement Therapies and Non-factor Therapy

Published: Nov-2017

Hemophilia is a rare disease affecting more than 400,000 people worldwide. Hemophilia A is four to six times as common.....

$4995
More Info
Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2023 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth

Published: Oct-2017

Diabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycemia – high blood glucose levels.....

$4995
More Info
Global Respiratory Drugs Market to 2023 – A Changing Therapeutic Landscape as Key Patents Expire and Biologics, Targeted Therapies and CFTR Modulators for Asthma and Cystic Fibrosis Treatment Emerge as Market Growth Drivers

Published: Sep-2017

The respiratory therapy area consists of indications that affect the respiratory system in different ways, such as inflammation,.....

$4995
More Info
Global Diabetes Drugs Market to 2023 - A Diversifying Treatment Landscape as GLP-1 Receptor Agonists and SGLT-2 Inhibitors Gain Ground Following Landmark Cardiac Outcomes

Published: Sep-2017

This report provides insight into the diversifying and highly lucrative diabetes mellitus (DM) market. Analysis has identified.....

$4995
More Info
Hepatitis C Therapeutics in Asia-Pacific Markets to 2023 – Presence of Outstanding Direct-Acting Antivirals and Late-Stage Pipeline to Transform the Clinical and Commercial Landscape

Published: Aug-2017

Hepatitis C is a blood-borne liver disease caused by the hepatitis C virus (HCV), which can lead to acute and chronic.....

$4995
More Info
Global Ophthalmology Drugs Market to 2023- Angiogenesis Inhibitors in wAMD Set to Retain High Market Share, While Expansive Pipeline for Glaucoma Leads the Research Landscape

Published: Aug-2017

Ophthalmology is a broad therapy area that consists of almost 100 disorders associated with the eyes and visual system,.....

$4995
More Info
25%
off
Global Dermatology Drugs Market to 2023 – Growth Driven by Increased Uptake of Interleukin Receptor Inhibitors for Psoriasis and Atopic Dermatitis

Published: Jul-2017

Dermatology is a highly diverse therapy area that deals with diseases of the skin, hair and nails. Over 3,000 types of.....

Offer expires on Dec 22 2017

$4995
$3747
More Info
Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2023 – Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

Published: Jul-2017

Colorectal Cancer (CRC) is the most common cancer and the leading cause of cancer-related mortality globally. There were.....

$4995
More Info
Sort by: